Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.

Jean-Gilles L, Braitch M, Latif ML, Aram J, Fahey AJ, Edwards LJ, Robins RA, Tanasescu R, Tighe PJ, Gran B, Showe LC, Alexander SP, Chapman V, Kendall DA, Constantinescu CS.

Acta Physiol (Oxf). 2015 Feb 23. doi: 10.1111/apha.12474. [Epub ahead of print]

PMID:
25704169
2.

Comparative functional genomics of adaptation to muscular disuse in hibernating mammals.

Fedorov VB, Goropashnaya AV, Stewart NC, Tøien Ø, Chang C, Wang H, Yan J, Showe LC, Showe MK, Barnes BM.

Mol Ecol. 2014 Nov;23(22):5524-37. doi: 10.1111/mec.12963. Epub 2014 Nov 3.

PMID:
25314618
3.

Inflammation and Its Correlates in Regenerative Wound Healing: An Alternate Perspective.

Gourevitch D, Kossenkov AV, Zhang Y, Clark L, Chang C, Showe LC, Heber-Katz E.

Adv Wound Care (New Rochelle). 2014 Sep 1;3(9):592-603. Review.

4.

The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells.

Wang H, Geng J, Wen X, Bi E, Kossenkov AV, Wolf AI, Tas J, Choi YS, Takata H, Day TJ, Chang LY, Sprout SL, Becker EK, Willen J, Tian L, Wang X, Xiao C, Jiang P, Crotty S, Victora GD, Showe LC, Tucker HO, Erikson J, Hu H.

Nat Immunol. 2014 Jul;15(7):667-75. doi: 10.1038/ni.2890. Epub 2014 May 25.

5.

Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection.

Dawany N, Showe LC, Kossenkov AV, Chang C, Ive P, Conradie F, Stevens W, Sanne I, Azzoni L, Montaner LJ.

PLoS One. 2014 Feb 25;9(2):e89925. doi: 10.1371/journal.pone.0089925. eCollection 2014.

6.

Fine-mapping quantitative trait loci affecting murine external ear tissue regeneration in the LG/J by SM/J advanced intercross line.

Cheverud JM, Lawson HA, Bouckaert K, Kossenkov AV, Showe LC, Cort L, Blankenhorn EP, Bedelbaeva K, Gourevitch D, Zhang Y, Heber-Katz E.

Heredity (Edinb). 2014 May;112(5):508-18. doi: 10.1038/hdy.2013.133. Epub 2014 Feb 26.

PMID:
24569637
7.

Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.

Pal S, Bi Y, Macyszyn L, Showe LC, O'Rourke DM, Davuluri RV.

Nucleic Acids Res. 2014 Apr;42(8):e64. doi: 10.1093/nar/gku121. Epub 2014 Feb 6.

8.

The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.

Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, Liu Q, Shimono A, Sudol M, Holmgren L, Stanger BZ, Kissil JL.

Sci Signal. 2013 Sep 3;6(291):ra77. doi: 10.1126/scisignal.2004060.

9.

Retraction: Sp100 as a potent tumor suppressor: accelerated senescence and rapid malignant transformation of human fibroblasts through modulation of an embryonic stem cell program.

Negorev DG, Vladimirova OV, Kossenkov AV, Demarest RM, Showe MK, Rauscher FJ 3rd, Showe LC, Nikonova EV, Capobianco AJ.

Cancer Res. 2013 Aug 1;73(15):4960-1. doi: 10.1158/0008-5472.CAN-13-1715. No abstract available.

10.

CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients.

Wysocka M, Kossenkov AV, Benoit BM, Troxel AB, Singer E, Schaffer A, Kim B, Dentchev T, Nagata S, Ise T, Showe LC, Rook AH.

J Invest Dermatol. 2014 Jan;134(1):229-36. doi: 10.1038/jid.2013.279. Epub 2013 Jun 21.

11.

Single cell analysis of RNA-mediated histone H3.3 recruitment to a cytomegalovirus promoter-regulated transcription site.

Newhart A, Rafalska-Metcalf IU, Yang T, Joo LM, Powers SL, Kossenkov AV, Lopez-Jones M, Singer RH, Showe LC, Skordalakes E, Janicki SM.

J Biol Chem. 2013 Jul 5;288(27):19882-99. doi: 10.1074/jbc.M113.473181. Epub 2013 May 20.

12.

MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor.

Chakraborty AR, Robey RW, Luchenko VL, Zhan Z, Piekarz RL, Gillet JP, Kossenkov AV, Wilkerson J, Showe LC, Gottesman MM, Collie NL, Bates SE.

Blood. 2013 May 16;121(20):4115-25. doi: 10.1182/blood-2012-08-449140. Epub 2013 Mar 26.

13.

Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility.

Tavecchio M, Lisanti S, Lam A, Ghosh JC, Martin NM, O'Connell M, Weeraratna AT, Kossenkov AV, Showe LC, Altieri DC.

J Biol Chem. 2013 Feb 22;288(8):5553-61. doi: 10.1074/jbc.M112.433045. Epub 2013 Jan 9.

14.

Correlates of relative resistance against low-dose rectal simian immunodeficiency virus challenges in peripheral blood mononuclear cells of vaccinated rhesus macaques.

Kurupati R, Tuyishime S, Kossenkov AV, Sazanovich M, Haut LH, Lasaro MO, Ratcliffe SJ, Bosinger SE, Carnathan DG, Lewis M, Showe LC, Silvestri G, Ertl HC.

J Leukoc Biol. 2013 Mar;93(3):437-48. doi: 10.1189/jlb.0612287. Epub 2012 Dec 27.

15.

The peripheral immune response and lung cancer prognosis.

Showe MK, Kossenkov AV, Showe LC.

Oncoimmunology. 2012 Nov 1;1(8):1414-1416.

16.

Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles.

Tchou J, Kossenkov AV, Chang L, Satija C, Herlyn M, Showe LC, Puré E.

BMC Med Genomics. 2012 Sep 6;5:39. doi: 10.1186/1755-8794-5-39.

17.

Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.

Lopergolo A, Tavecchio M, Lisanti S, Ghosh JC, Dohi T, Faversani A, Vaira V, Bosari S, Tanigawa N, Delia D, Kossenkov AV, Showe LC, Altieri DC.

Cancer Res. 2012 Jul 1;72(13):3251-9. doi: 10.1158/0008-5472.CAN-11-4035. Epub 2012 May 14.

18.

Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer.

Kossenkov AV, Dawany N, Evans TL, Kucharczuk JC, Albelda SM, Showe LC, Showe MK, Vachani A.

PLoS One. 2012;7(3):e34392. doi: 10.1371/journal.pone.0034392. Epub 2012 Mar 29.

19.

The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.

Zhou C, Licciulli S, Avila JL, Cho M, Troutman S, Jiang P, Kossenkov AV, Showe LC, Liu Q, Vachani A, Albelda SM, Kissil JL.

Oncogene. 2013 Feb 14;32(7):903-9. doi: 10.1038/onc.2012.99. Epub 2012 Mar 19.

20.

The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.

Kelly-Sell MJ, Kim YH, Straus S, Benoit B, Harrison C, Sutherland K, Armstrong R, Weng WK, Showe LC, Wysocka M, Rook AH.

Am J Hematol. 2012 Apr;87(4):354-60. doi: 10.1002/ajh.23112. Epub 2012 Feb 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk